BIO-ORTHOGONAL DRUG ACTIVATION

The invention relates to a Prodrug activation method, for therapeutics, wherein use is made of abiotic reactive chemical groups that exhibit bio-orthogonal reactivity towards each other. The invention also relates to a Prodrug kit comprising at least one Prodrug and at least one Activator, wherein t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ROSSIN RAFFAELLA, JANSSEN HENDRICUS MARIE, ROBILLARD MARC STEFAN, TEN HOEVE WOLTER, VERSTEEGEN RONNY MATHIEU
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ROSSIN RAFFAELLA
JANSSEN HENDRICUS MARIE
ROBILLARD MARC STEFAN
TEN HOEVE WOLTER
VERSTEEGEN RONNY MATHIEU
description The invention relates to a Prodrug activation method, for therapeutics, wherein use is made of abiotic reactive chemical groups that exhibit bio-orthogonal reactivity towards each other. The invention also relates to a Prodrug kit comprising at least one Prodrug and at least one Activator, wherein the Prodrug comprises a Drug and a first Bio-orthogonal Reactive Group (the Trigger), and wherein the Activator comprises a second Bio-orthogonal Reactive Group. The invention also relates to targeted therapeutics used in the above-mentioned method and kit. The invention particularly pertains to antibody-drug conjugates and to bi- and trispecific antibody derivatives.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2016106859A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2016106859A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2016106859A13</originalsourceid><addsrcrecordid>eNrjZJBz8vTX9Q8K8fB39_dz9FFwCQp1V3B0DvEMcwzx9PfjYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoZmhgZmFqaWjobGxKkCAEMwIm0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>BIO-ORTHOGONAL DRUG ACTIVATION</title><source>esp@cenet</source><creator>ROSSIN RAFFAELLA ; JANSSEN HENDRICUS MARIE ; ROBILLARD MARC STEFAN ; TEN HOEVE WOLTER ; VERSTEEGEN RONNY MATHIEU</creator><creatorcontrib>ROSSIN RAFFAELLA ; JANSSEN HENDRICUS MARIE ; ROBILLARD MARC STEFAN ; TEN HOEVE WOLTER ; VERSTEEGEN RONNY MATHIEU</creatorcontrib><description>The invention relates to a Prodrug activation method, for therapeutics, wherein use is made of abiotic reactive chemical groups that exhibit bio-orthogonal reactivity towards each other. The invention also relates to a Prodrug kit comprising at least one Prodrug and at least one Activator, wherein the Prodrug comprises a Drug and a first Bio-orthogonal Reactive Group (the Trigger), and wherein the Activator comprises a second Bio-orthogonal Reactive Group. The invention also relates to targeted therapeutics used in the above-mentioned method and kit. The invention particularly pertains to antibody-drug conjugates and to bi- and trispecific antibody derivatives.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160421&amp;DB=EPODOC&amp;CC=US&amp;NR=2016106859A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160421&amp;DB=EPODOC&amp;CC=US&amp;NR=2016106859A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ROSSIN RAFFAELLA</creatorcontrib><creatorcontrib>JANSSEN HENDRICUS MARIE</creatorcontrib><creatorcontrib>ROBILLARD MARC STEFAN</creatorcontrib><creatorcontrib>TEN HOEVE WOLTER</creatorcontrib><creatorcontrib>VERSTEEGEN RONNY MATHIEU</creatorcontrib><title>BIO-ORTHOGONAL DRUG ACTIVATION</title><description>The invention relates to a Prodrug activation method, for therapeutics, wherein use is made of abiotic reactive chemical groups that exhibit bio-orthogonal reactivity towards each other. The invention also relates to a Prodrug kit comprising at least one Prodrug and at least one Activator, wherein the Prodrug comprises a Drug and a first Bio-orthogonal Reactive Group (the Trigger), and wherein the Activator comprises a second Bio-orthogonal Reactive Group. The invention also relates to targeted therapeutics used in the above-mentioned method and kit. The invention particularly pertains to antibody-drug conjugates and to bi- and trispecific antibody derivatives.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJBz8vTX9Q8K8fB39_dz9FFwCQp1V3B0DvEMcwzx9PfjYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXxocFGBoZmhgZmFqaWjobGxKkCAEMwIm0</recordid><startdate>20160421</startdate><enddate>20160421</enddate><creator>ROSSIN RAFFAELLA</creator><creator>JANSSEN HENDRICUS MARIE</creator><creator>ROBILLARD MARC STEFAN</creator><creator>TEN HOEVE WOLTER</creator><creator>VERSTEEGEN RONNY MATHIEU</creator><scope>EVB</scope></search><sort><creationdate>20160421</creationdate><title>BIO-ORTHOGONAL DRUG ACTIVATION</title><author>ROSSIN RAFFAELLA ; JANSSEN HENDRICUS MARIE ; ROBILLARD MARC STEFAN ; TEN HOEVE WOLTER ; VERSTEEGEN RONNY MATHIEU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2016106859A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>ROSSIN RAFFAELLA</creatorcontrib><creatorcontrib>JANSSEN HENDRICUS MARIE</creatorcontrib><creatorcontrib>ROBILLARD MARC STEFAN</creatorcontrib><creatorcontrib>TEN HOEVE WOLTER</creatorcontrib><creatorcontrib>VERSTEEGEN RONNY MATHIEU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ROSSIN RAFFAELLA</au><au>JANSSEN HENDRICUS MARIE</au><au>ROBILLARD MARC STEFAN</au><au>TEN HOEVE WOLTER</au><au>VERSTEEGEN RONNY MATHIEU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>BIO-ORTHOGONAL DRUG ACTIVATION</title><date>2016-04-21</date><risdate>2016</risdate><abstract>The invention relates to a Prodrug activation method, for therapeutics, wherein use is made of abiotic reactive chemical groups that exhibit bio-orthogonal reactivity towards each other. The invention also relates to a Prodrug kit comprising at least one Prodrug and at least one Activator, wherein the Prodrug comprises a Drug and a first Bio-orthogonal Reactive Group (the Trigger), and wherein the Activator comprises a second Bio-orthogonal Reactive Group. The invention also relates to targeted therapeutics used in the above-mentioned method and kit. The invention particularly pertains to antibody-drug conjugates and to bi- and trispecific antibody derivatives.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2016106859A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title BIO-ORTHOGONAL DRUG ACTIVATION
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T01%3A44%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ROSSIN%20RAFFAELLA&rft.date=2016-04-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2016106859A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true